Financial Statements (unaudited)
ITEM 1. FINANCIAL STATEMENTS. 2 PETMED EXPRESS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except for share and per share amounts) June 30, 2026 March 31, 2026 (Unaudited) ASSETS Current assets: Cash and cash equivalents $ 13,079 $ 21,412 Accounts receivable, less allowance for credit losses of $ 0 and $ 25 , respectively 1,706 1,908 Inventories, net 8,468 13,608 Prepaid expenses and other current assets 4,256 6,378 Prepaid income taxes 96 258 Total current assets 27,605 43,564 Noncurrent assets: Property and equipment, net 25,213 26,326 Intangible and other assets, net 10,549 10,789 Operating lease right-of-use assets 395 512 Total noncurrent assets 36,157 37,627 Total assets $ 63,762 $ 81,191 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 12,298 $ 20,906 Sales tax payable 20,603 22,261 Accrued expenses and other current liabilities 6,654 7,665 Current operating lease liabilities 414 493 Deferred revenue 629 689 Income taxes payable — 20 Total current liabilities 40,598 52,034 Deferred tax liabilities, net 175 175 Operating lease liabilities, net of current lease liabilities — 42 Total liabilities 40,773 52,251 Commitments and contingencies (Note 7) Shareholders' equity: Preferred stock, $ 0.001 par value, 5,000,000 shares authorized: Convertible preferred stock, $ 0.001 par value, with a liquidation preference of $ 4 per share, 250,000 shares authorized; 2,500 and 2,500 convertible shares issued and outstanding, respectively 9 9 Series A Junior Participating Preferred Stock, $ 0.001 par value, 100,000 shares authorized; no shares issued or outstanding — — Common stock, $ .001 par value, 40,000,000 shares authorized; 21,682,381 and 21,385,638 shares issued and outstanding, respectively 22 21 Additional paid-in capital 19,840 19,647 Retained earnings 3,118 9,263 Total shareholders' equity 22,989 28,940 Total liabilities and shareholders' equity $ 63,762 $ 81,191 See accompanying notes to unaudited condensed consolidated financial statements. 3 PETMED EXPRESS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except for share and per share amounts) (Unaudited) Three Months Ended June 30, 2026 2025 Net sales $ 41,015 $ 51,180 Cost of sales 29,682 36,777 Gross profit 11,333 14,403 Operating expenses: General and administrative 11,197 12,948 Advertising 4,220 6,046 D